Details

NameSymbolSector
MANGALAM DRUGS AND ORGANICS LTD.MANGALAMPharmaceuticals
Open
30.1
High
30.1
Low
28.83
Close
29.33
Volume
14010
Exchange
nse
Time
08-Sep-2026

Outlook

Score:

2.75

Rating:

RISKY

Candlestick Pattern

CandlepatternofMangalamDrugsAndOrganicsis
None
EstimatedStoplossofMangalamDrugsAndOrganicsis
30.1
MangalamDrugsAndOrganicshasa
Bearishℹ
pattern.
Formationof
None
candlepatternindicatesthetrenddirectionofMangalamDrugsAndOrganicsis
Unpredictableℹ
.

Trend

MangalamDrugsAndOrganicsisin
Sideways trendℹ
.
PriceofMangalamDrugsAndOrganicsis
Upℹ
by

3.6

%.
Target
Buy@

25.92

Sell@

30.7

Current@

29.33

Volume

ThetradevolumesofMangalamDrugsAndOrganicshavebecome
Deficientℹ
ThoughthevolumetrendforMangalamDrugsAndOrganicsappears
Bullishℹ
theparticipantsseemtobe
Weak Buyersℹ
ThetradevolumeofMangalamDrugsAndOrganicsis

Down

by

47.67

%

Valuation

ThecurrentmarketpriceofMangalamDrugsAndOrganicsis
Undervaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth366crandtotalassetsworth366cr,thebalancesheetofMangalamDrugsAndOrganicsis:
Balancedℹ
.
Cashflow
MangalamDrugsAndOrganicshas
Maintainedℹ
cashflowbecausethereis

Surplus

of

₹ 1cr

.Itis
Upℹ
by

150

%.
51.22% i.e. ₹ 42cr earned in operatingℹ
23.17% i.e. ₹ 19cr spent in investingℹ
25.61% i.e. ₹ 21cr spent in financingℹ
0% in otherℹ
MangalamDrugsAndOrganicshas
Insufficientℹ
cashflowbecausethereis

Shortage

of

₹ 2cr

.Itis
Downℹ
by

0

%.
15.79% i.e. ₹ 3cr earned in operatingℹ
57.89% i.e. ₹ 11cr spent in investingℹ
26.32% i.e. ₹ 5cr earned in financingℹ
0% in otherℹ
Income
TheincomeofMangalamDrugsAndOrganicsis

₹ 49cr

and

Loss

is:

₹ 7cr

MangalamDrugsAndOrganicsLossesdecreasedby:

46.15

%andIncomeisDownby:

14.04

%
TheincomeofMangalamDrugsAndOrganicsis

₹ 57cr

and

Loss

is:

₹ 13cr

MangalamDrugsAndOrganicsLossesincreasedby:

1300

%andIncomeisDownby:

21.92

%
TheincomeofMangalamDrugsAndOrganicsis

₹ 73cr

and

Loss

is:

₹ 0cr

MangalamDrugsAndOrganicsLossesincreasedby:

100

%andIncomeisDownby:

17.05

%
By using this site you agree to the use of cookies to deliver a better site experience.